Skip to content
The GLP-1 Verdict
Menu

The alternatives

The best alternatives to Harper Meds

Harper Meds scores 73/100 (grade C, ranked #104) on The Verdict Score. Here are the top-rated GLP-1 providers we'd weigh against it — same six-factor rubric, and no score is adjusted for payment.

Harper Meds — FDA warning letter, June 2026. Addressed to Nexus Health Solutions LLC dba Harper Meds, and public in FDA’s warning-letter database.

Read our full Harper Meds review →

Grade C

GOAL.MD

GOAL.MD is a St. Louis-based telehealth platform offering compounded semaglutide alongside brand-name bridges to Ozempic, Wegovy, and Zepbound. Its standout is a manual-renewal model — no auto-billing

GOAL.MD matches Harper Meds at 73/100; our full write-up on GOAL.MD has the pricing conditions and the caveats in detail.

Sema
$99/mo
Tirz
From $249/mo (starting dose, compounded)
Coverage
All 50 states
Grade C

Ivy Rx

Telehealth provider offering tiered compounded semaglutide and tirzepatide programs.

Ivy Rx matches Harper Meds at 73/100; our full write-up on Ivy Rx has the pricing conditions and the caveats in detail.

Sema
From $175/mo (starting dose, compounded)
Tirz
From $275/mo (starting dose, compounded)
Coverage
All 50 states
Grade C

Corsica Health

Corsica Health is a telehealth platform offering both compounded GLP-1s and brand-name FDA-approved injections through a structured assessment, provider review, and medication flow.

Corsica Health matches Harper Meds at 73/100; our full write-up on Corsica Health has the pricing conditions and the caveats in detail.

Sema
From $249/mo (compounded)
Tirz
From $349/mo (compounded)
Coverage
Not disclosed
Grade C

Kina

Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms.

Kina matches Harper Meds at 73/100; the full Kina review has the pricing conditions and the caveats in detail.

Sema
From $179/mo (starting dose, plus a separate fee, compounded)
Tirz
From $179/mo (starting dose, compounded)
Coverage
Not disclosed
Grade C

Amble

Telehealth weight loss provider offering compounded semaglutide and tiered tirzepatide programs.

Amble matches Harper Meds at 73/100; the full Amble review has the pricing conditions and the caveats in detail.

Sema
From $179/mo (starting dose, compounded)
Tirz
From $289/mo (starting dose, compounded)
Coverage
All 50 states
Grade C

Layla

Layla is a US telehealth weight-loss program built around semaglutide, offering compounded semaglutide as injections and as oral dropper drops, plus compounded tirzepatide and a brand-inclusive GLP-1…

Layla matches Harper Meds at 73/100; our Layla ruling in full has the pricing conditions and the caveats in detail.

Sema
From $237/mo (all doses, compounded)
Tirz
From $199/mo (all doses, compounded)
Coverage
Not disclosed

See the complete rankings or head to the comparison hub.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.